Total Results: 491

Gottlieb Says He Can Be Most Effective At FDA, But Dodges Question On Nomination Talks

KHN Morning Briefing

“I feel like I want to continue to follow through on the policies we’ve put out and it’s where I think I can be most effective,” said Food and Drug Administration Commissioner Scott Gottlieb, whose name has been floated as a replacement for former Health and Human Services Secretary Tom Price. Meanwhile, President Donald Trump names an acting secretary for the agency.

10 Years Ago This Lawyer Went Up Against Pharma Over Opioids And Won. Now He’s Ready For Round Two.

KHN Morning Briefing

Back in 2007, Purdue settled with individual patients who alleged that it had underplayed the addiction risk of its medications. It was a huge case for lawyer Paul Hanly and a rare win against makers of painkillers. Now, in an entirely different landscape — one where these companies are becoming the targets of states who want to try to curb the national crisis — Hanly is gearing up to go again. Meanwhile, PBS looks at how the brain gets addicted to opioids in the first place.

In Effort To Slow Opioid Epidemic, Cigna Drops Coverage For OxyContin

KHN Morning Briefing

Instead, the insurer will cover Xtampza ER, which it calls an “oxycodone equivalent with abuse deterrent properties.” In other news on the nation’s drug crisis: federal officials look to Buffalo’s opioid crisis intervention court as a potential model; a Texas county is the latest to sue drug companies for their alleged role in the epidemic; researchers turn to virtual reality for pain solutions; and more.

Early Approval Of Generic MS Drug Signals Big Changes For Teva And Other Drugmakers

KHN Morning Briefing

Teva had lobbied the Food and Drug Administration to reject Mylan’s generic version of its Copaxone multiple sclerosis medication. In other drug industry news: an experimental drug is found to work on a mutant gene; advocates await Calif. Gov. Jerry Brown’s decision on a drug pricing bill; and Cleveland Clinic’s CEO wants supporters of a drug pricing ballot measure in Ohio to stop using his image.